参考文献/References:
[1] Rakshi JS, Uema T, Ito K, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson’s disease A 3D 18F-dopa-PET study[J]. Brain, 1999, 122(Pt 9):1637-1650.
[2] Hwang WJ, Yao WJ, Wey SP, et al. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson’s disease[J]. J Nucl Med, 2004, 45(2):207-213.
[3] Schreckenberger M, Hagele S, Siessmeier T, et al. The dopamine D2 receptor ligand 18F-desmethoxflallypride:an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism[J]. Eur J Nucl Med Mol Imaging, 2004, 31(8):1128-1135.
[4] Pavese N, Evans AH, Tai YF, et al. Clinical correlates of levodopainduced dopamine release in Parkinson disease:a PET study[J]. Neurology, 2006, 67(9):1612-1617.
[5] 左传涛,林祥通,李殿友,等.晚期帕金森病患者脑内18F-FDG摄取变化及其异常脑内环路机制的探讨[J].中华核医学杂志,2004,24(2):107-109.
[6] Feigin A, Kaplitt MG, Tang C, et al. Modulation of metabolic brain networks aftcr subthalamic gene therapy for Parkinson’s disease[J]. Proc Nad Acad Sci USA, 2007, 104(49):19559-19564.
[7] Henry TR, Van Heertum RL, et al. Positron emission tomography and single photon emisssion computed tomography in epilepsy care[J]. Semin Nucl Med, 2003, 33(2):88-104.
[8] Fedi M, Berkovic SF, Marini C, et al. A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding[J]. Neuroing, 2006, 32(3):995-1000.
[9] Bouvard S, Costes N, Bonnefoi F, et al. Seizure-related short-term plasticity of benzodiazeplne receptors in partial epilepsy:a 11C-flumazenil-PET study[J]. Brain, 2005, 128(Pt6):1330-1343.
[10] Umeoka S, Matsuda K, Baba K, et al. Usefulness of 123I-iomazenil single-photon emission computed tomography in discriminating between mesial and lateral temporal lobe epilepsy in patients in whom magnetic resonance imaging demonstrates normal findings[J]. Neurosurg, 2007, 107(2):352-363.
[11] Goerres GW, Revesz T, Duncan J, et al. Imaging cerebral vasculitis in refractory epilepsy using 11C (R)-PK11195 positron emission tomography[J]. Am J Roentgenol, 2001, 176(4):1016-1018.
[12] Drayer B, Jaszczak R, Coleman E, et al. Muscarinic cholinergic receptor binding:In vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate[J]. J Comput Assist Tomogr, 1982, 6(3):536-543.
[13] Herholz K, Weisenbach S, Zündorf G, et al. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease[J]. Neuroimage, 2004, 21(1):136-143.
[14] Bohnen NI, Kaufer DI, Hendrickson R, et al. Cognitive correlates of alterations in aeetyleholinesterase in Alzheimer’s disease. Neurosci Lett, 2005, 380(1-2):127-132.
[15] Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B[J]. Ann Neurol, 2004, 55(3):306-319.
[16] Mintun MA, Larossa GN, Sheline YI,et al. 11C-PIB in a nondemented population:potential antecedent marker of Alzheimer disease[J]. Neurology, 2006, 67(3):446-452.
[17] Yoshita M, Taki J, Yokoyama K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD[J]. Neurology, 2006, 66(12):1850-1854.
[18] Hanyu H, Shimizu S, Hirao K, et al. Comparative value of brain perfusion SPECT and 123I-MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer’s disease[J]. Eur J Nucl Med Mol Imaging, 2006, 33(3):248-253.
[19] Volkow ND, Chang L, Wang GJ, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence[J]. J Neurosci, 2001, (23):9414-9418.
[20] Volkow ND, Fowler JS, Gatley SJ, et al. PET evaluation of the dopamine system of the human brain[J]. J Nucl Med, 1996, 37(7):1242-1256.
[21] Chon Y H, Huang WS, Su TP, et al. Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence:A SPECT study[J]. Eur Neuropsychopharmacol, 2007, 17(1):46-52.
[22] Potkin SG, Alva G, Fleming K, et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography[J]. Am J Psychiatry, 2002, 159(2):227-237.
[23] Parsey RV, Hastings RS, Oquendo MA. et al. Lower semtonin transporter binding potential in the human brain during major depressive episodes[J]. Am J Psychiatry, 2006, 163(1):52-58.
[24] Yasuno F, Suhara T, Okubo Y, et al. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia[J]. Psychiatry Res, 2005, 138(3):197-207.
[25] Feng CM, Narayana S, Lancaster JL, et al. CBF changes during brain activation:fMRI vs. PET. Neuroimage, 2004, 22(1):443-446.
[26] Laureys S, Owen AM, Schiff ND. Brain function in coma, vegetative state, and related disorders. Lancet Neurol, 2004, 3(9):537-546.
[27] 张向宇,高硕,赵建国,等.不同穴位组合对脑梗死患者脑葡萄糖代谢的影响——PET研究[J].中国针灸,2007,27(1):26-30.
[28] Palmedo H, Urbach H, Bender H, et al. FDG-PET in immunocompetent patients with primary central nervous system lymphoma:correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging, 2006, 33(2):164-168.
相似文献/References:
[1]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]孙芳芳,张欣.uPAR放射性核素靶向显像研究进展[J].国际放射医学核医学杂志,2016,40(3):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
Sun Fangfang,Zhang Xin.Research progress of uPAR-targeted nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
[5]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[6]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[7]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
[8]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
[9]吕靖,张一帆.核素分子显像监测胚胎干细胞及诱导性多潜能干细胞移植的研究进展[J].国际放射医学核医学杂志,2014,38(2):106.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
Lyu Jing,Zhang Yifan.Advances in radionuclide imaging of monitoring embryonic stem cells and induced pluripotent stem cells transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):106.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
[10]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[11]邱春,管一晖.5-羟色胺受体显像剂在神经系统疾病及脑功能研究中的应用[J].国际放射医学核医学杂志,2011,35(2):73.[doi:10.3760/cma.j.issn.1673-4114.2011.02.003]
QIU Chun,GUAN Yi-hui.Application of 5-hydroxytryptamine receptor imaging for study of neuropsychiatric disorders and brain functions[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):73.[doi:10.3760/cma.j.issn.1673-4114.2011.02.003]